Page last updated: 2024-09-03

cgp 36742 and sincalide

cgp 36742 has been researched along with sincalide in 1 studies

Compound Research Comparison

Studies
(cgp 36742)
Trials
(cgp 36742)
Recent Studies (post-2010)
(cgp 36742)
Studies
(sincalide)
Trials
(sincalide)
Recent Studies (post-2010) (sincalide)
63324,01572533

Protein Interaction Comparison

ProteinTaxonomycgp 36742 (IC50)sincalide (IC50)
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.0006
Cholecystokinin receptor type AHomo sapiens (human)0.0006
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.001
Gastrin/cholecystokinin type B receptorMus musculus (house mouse)0.0008
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.0004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feligioni, M; Gemignani, A; Ghersi, C; Pittaluga, A; Raiteri, M1

Other Studies

1 other study(ies) available for cgp 36742 and sincalide

ArticleYear
Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA(B) receptor antagonists.
    Neuropharmacology, 2001, Volume: 41, Issue:3

    Topics: Animals; Cognition; Excitatory Amino Acid Antagonists; GABA Antagonists; GABA-B Receptor Antagonists; In Vitro Techniques; Male; Norepinephrine; Organophosphorus Compounds; Protein Kinase C; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Somatostatin; Sincalide; Somatostatin; Synaptosomes

2001